Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
About The Article: This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA ...
They’re used to treat type 2 diabetes and obesity.These drugs curb the cravings for high-calorie foods, helping users eat ...
MOUNTAIN VIEW, Calif., November 14, 2024--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in harnessing food molecules ...
News Medical on MSN1d
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetesTirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
Research has suggested that GLP-1 receptors in the brain may play a role in regulating mood and cognitive function, ...
Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...
More about APL-18881 (HEC88473) APL-18881 (HEC88473) is a bi-specific fusion protein developed by Sunshine Lake that agonizes FGF21 and GLP-1 receptors, both clinically validated targets ...
Olfactive Biosolutions’ Protenx™ GLP-1/GIP Weight Loss breakthrough food ingredients formulation activates olfactory receptors in the gut to induce the dual secretion of natural GLP-1 and GIP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback